TORONTO, ONTARIO — (Marketwired) — 07/10/13 — Corona Gold Corporation ("Corona") announces that it has received acceptance from the Toronto Stock Exchange ("TSX") of its Notice of Intention to make a Normal Course Issuer Bid to purchase its outstanding common shares from time to time in accordance with the normal course issuer bid procedures of the TSX and applicable Canadian securities laws.Pursuant to the issuer bid, Corona may purchase for cancellation up to 1,180,778
TORONTO, ONTARIO — (Marketwired) — 06/26/13 — The Board of Directors of Corona Gold Corporation (TSX: CRG) ("Corona") has authorized the purchase of up to the greater of (i) 5% of its outstanding common shares and (ii) 10% of its outstanding common shares not including shares held by directors and senior officers of Corona and persons that beneficially own, or exercise control or direction over, more than 10% of the common shares, by way of normal course purchases ("NCIB"
TORONTO, ONTARIO — (Marketwired) — 05/09/13 — Corona Gold Corporation ("Corona")(TSX: CRG) announces that Corona will hold its Annual and Special Meeting (the "Meeting") of shareholders on June 26, 2013 at 10:00 a.m. (Toronto Time) at the offices of Cassels, Brock & Blackwell LLP in Toronto, Canada. All shareholders of record as of May 6, 2013 are entitled to vote at the Meeting in person or by proxy.Corona further announces the approval by its board of directors (th
TORONTO, ONTARIO — (Marketwire) — 07/09/12 — Corona Gold Corporation ("Corona") (TSX: CRG) announces that it has received acceptance from the Toronto Stock Exchange ("TSX") of its Notice of Intention to make a Normal Course Issuer Bid to purchase its outstanding common shares from time to time in accordance with the normal course issuer bid procedures of the TSX and applicable Canadian securities laws.Pursuant to the issuer bid, Corona may purchase for cancellation up to
TORONTO, ONTARIO — (Marketwire) — 06/26/12 — The Board of Directors of Corona Gold Corporation (TSX: CRG) ("Corona") has authorized the purchase of up to the greater of (i) 5% of its outstanding common shares and (ii) 10% of its outstanding common shares not including shares held by directors and senior officers of Corona and persons that beneficially own, or exercise control or direction over, more than 10% of the common shares, by way of normal course purchases ("NCIB"
